Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- News2
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
Presenting Key Insights from the IMSS Survey at ECTRIMS 2024
We are excited to share that the European Multiple Sclerosis Platform (EMSP) has presented the preliminary findings from the Impact…
Engaging Expert Patients: MS CAB and EBV-MS Project Team Collaborate on Clinical Trial Design
On June 19, 2024, the Multiple Sclerosis Community Advisory Board (MS CAB) met with the EBV-MS project research team for…
EMSP Annual Conference 2023 – Social Policy: A Better Life for People with MS
People came from the warm shores of the Mediterranean, the colder climes of the Atlantic coast and central Europe… it…
EMSP @ ECTRIMS 2022 – Key takeaways
ECTRIMS is the world’s largest annual international conference devoted to basic and clinical research and care in multiple sclerosis. The…
ECTRIMS 2021 – Day 2 The Digital Experience Goes into the Next Round!
The themes of ECTRIMS Day 2 were spinning around Disease-Modifying Treatments (DMTs) addressing the question if and when to stop,…
ECTRIMS 2021 Day 1 – The Digital Experience in Multiple Sclerosis has started
This years’ ECTRIMS Congress – the 37th Congress of the European Committee for Treatment and Research in Multiple Sclerosis –…
